La société bretonne Hemarina a clôturé une levée de fonds de 8 millions d’euros pour commercialiser son produit “HEMO2life”, destiné à améliorer la conservation des greffons.

Source: Hemarina relève 8 millions d’euros pour préserver les greffons, Sciences & Prospectives 

In english => http://hemarina.com/index.php?rex=19&ctn=pub_aff_breve.318#pub_aff_breve.318


Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created www.augmented-reality.fr and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

0 Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.